Lewin C S, Morrissey I, Smith J T
Bacteriology Department, University of Edinburgh Medical School, UK.
Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):240-8. doi: 10.1007/BF01966996.
All 4-quinolones that have been examined display rapid bactericidal activity which is biphasic. At concentrations above the MIC, the lethality of the drugs increases until a concentration known as the optimum bactericidal concentration (OBC) beyond which the bactericidal activity then declines. The biphasic response appears to be due to the inhibition of RNA synthesis at concentrations above the OBC, as RNA synthesis is required for the full bactericidal activity of the 4-quinolones. However, differences in the biphasic response are observed as some fluoroquinolones are still able to kill bacteria in the absence of bacterial protein or RNA synthesis, thus reducing the inhibition of bactericidal activity at concentrations above the OBC. It has been proposed that this ability to kill bacteria in the absence of protein or RNA synthesis is due to the possession of an additional bactericidal mechanism by these fluoroquinolones. Oxygen also appears to be essential for the lethality of the clinically available 4-quinolones although it is not required for the drugs to inhibit bacterial multiplication. Therefore these drugs are not bactericidal under anaerobic conditions.
所有已检测的4-喹诺酮类药物均显示出具有双相性的快速杀菌活性。在高于最低抑菌浓度(MIC)的浓度下,药物的致死率会增加,直至达到一个被称为最佳杀菌浓度(OBC)的浓度,超过该浓度后杀菌活性便会下降。这种双相反应似乎是由于在高于OBC的浓度下RNA合成受到抑制,因为RNA合成是4-喹诺酮类药物充分发挥杀菌活性所必需的。然而,观察到双相反应存在差异,因为一些氟喹诺酮类药物在没有细菌蛋白质或RNA合成的情况下仍能杀死细菌,从而降低了在高于OBC的浓度下对杀菌活性的抑制。有人提出,这些氟喹诺酮类药物在没有蛋白质或RNA合成的情况下杀死细菌的能力是由于它们拥有额外的杀菌机制。氧气似乎对临床可用的4-喹诺酮类药物的致死性也至关重要,尽管药物抑制细菌繁殖并不需要氧气。因此,这些药物在厌氧条件下不具有杀菌作用。